ABOS — Acumen Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Acumen Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	43.8	194	178	244	172
Net Total Receivables	0.109	0	—	—	0.398
Prepaid Expenses
Total Other Current Assets
Total Current Assets	44.4	199	180	247	178
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	0.036	0.27	0.503	0.339
Long Term Investments
Other Long Term Assets
Total Assets	44.4	230	197	310	239
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6.37	5.15	7.81	13	27.6
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6.37	5.15	7.81	43.2	57.2
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	38.1	225	189	267	182
Total Liabilities & Shareholders' Equity	44.4	230	197	310	239
Total Common Shares Outstanding